BioStem Technologies, Inc.
BSEM
$3.71
$0.102.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 28.75% | -39.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 28.75% | -39.12% | |||
| Cost of Revenue | 28.73% | 692.79% | |||
| Gross Profit | 28.76% | -61.55% | |||
| SG&A Expenses | 7.77% | -30.38% | |||
| Depreciation & Amortization | 27.55% | 1,047.35% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.52% | -14.55% | |||
| Operating Income | 5.45% | -18.46% | |||
| Income Before Tax | -1.72% | -20.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -1.72% | 21.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.72% | 21.68% | |||
| EBIT | 5.45% | -18.46% | |||
| EBITDA | 7.58% | -11.96% | |||
| EPS Basic | 1.09% | 22.85% | |||
| Normalized Basic EPS | 7.64% | -18.73% | |||
| EPS Diluted | 0.65% | 22.85% | |||
| Normalized Diluted EPS | 7.64% | -18.73% | |||
| Average Basic Shares Outstanding | 2.83% | 1.52% | |||
| Average Diluted Shares Outstanding | 2.83% | 1.52% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||